Pulmonary Toxicities Related to Cancer Treatment

Host: Gerard A. Silvestri MD, MS, FCCP <br> Guest: Lynn Tanoue, MD, MBA <br> <p>About 10 percent of all cancer patients develop treatment-related pulmonary complications, and for lung cancer patients, that risk is even greater. Dr. Gerard Silvestri sits down with Dr. Lynn Tanoue, Professor of Medicine and Vice Chair of Clinical Affairs in the section of pulmonary critical care and sleep medicine at the Yale Cancer Center in New Haven, Connecticut, to discuss pulmonary toxicities related to lung cancer treatment.<br /><br /><em>An educational campaign brought to you by CHEST, in collaboration with AstraZeneca</em>.</p>